PNC Financial Services Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96 | Sell |
85
-257
| -75% | -$290 | ﹤0.01% | 4838 |
|
|
2025
Q1 | $499 | Buy |
342
+154
| +82% | +$225 | ﹤0.01% | 4646 |
|
|
2024
Q4 | $400 | Buy |
188
+10
| +6% | +$21 | ﹤0.01% | 4562 |
|
|
2024
Q3 | $498 | Sell |
178
-2,500
| -93% | -$6.99K | ﹤0.01% | 4567 |
|
|
2024
Q2 | $6.24K | Hold |
2,678
| – | – | ﹤0.01% | 3931 |
|
|
2024
Q1 | $12K | Hold |
2,678
| – | – | ﹤0.01% | 3678 |
|
|
2023
Q4 | $8.6K | Sell |
2,678
-194
| -7% | -$623 | ﹤0.01% | 3778 |
|
|
2023
Q3 | $9.1K | Buy |
2,872
+372
| +15% | +$1.18K | ﹤0.01% | 3793 |
|
|
2023
Q2 | $12.4K | Sell |
2,500
-31
| -1% | -$154 | ﹤0.01% | 3778 |
|
|
2023
Q1 | $12.5K | Hold |
2,531
| – | – | ﹤0.01% | 3708 |
|
|
2022
Q4 | $15.9K | Hold |
2,531
| – | – | ﹤0.01% | 3582 |
|
|
2022
Q3 | $27K | Hold |
2,531
| – | – | ﹤0.01% | 3299 |
|
|
2022
Q2 | $29K | Sell |
2,531
-450
| -15% | -$5.16K | ﹤0.01% | 3295 |
|
|
2022
Q1 | $27K | Buy |
2,981
+17
| +0.6% | +$154 | ﹤0.01% | 3430 |
|
|
2021
Q4 | $44K | Buy |
2,964
+14
| +0.5% | +$208 | ﹤0.01% | 3173 |
|
|
2021
Q3 | $76K | Sell |
2,950
-19
| -0.6% | -$489 | ﹤0.01% | 2808 |
|
|
2021
Q2 | $77K | Buy |
2,969
+19
| +0.6% | +$493 | ﹤0.01% | 2805 |
|
|
2021
Q1 | $104K | Hold |
2,950
| – | – | ﹤0.01% | 2553 |
|
|
2020
Q4 | $74K | Hold |
2,950
| – | – | ﹤0.01% | 2668 |
|
|
2020
Q3 | $111K | Buy |
2,950
+450
| +18% | +$16.9K | ﹤0.01% | 2262 |
|
|
2020
Q2 | $107K | Buy |
+2,500
| New | +$107K | ﹤0.01% | 2286 |
|